Compare $CTKB vs $CYRX | Chartloom

Compare

$CTKB vs $CYRX

Cytek Biosciences Inc · Cryoport Inc

CTKB

Cytek Biosciences Inc

CYRX

Cryoport Inc

Compare $CTKB vs $CYRX

Comparing Cytek Biosciences Inc and Cryoport Inc

CTKBCytek Biosciences Inc

CYRXCryoport Inc

CTKBCytek Biosciences Inc

Market cap

$701M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.18x

Rev growth (TTM)

5.4%

YTD performance

10.4%

52W performance

39.2%

FCF yield

-1.7%

CYRXCryoport Inc

Market cap

$874M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-8.0%

YTD performance

81.5%

52W performance

72.5%

FCF yield

-2.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTKB

CYRX

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

CYRX

Cryoport Inc

Market Cap

CTKB$701M

CYRX$874M

Enterprise Value

CTKB$637M

CYRX$793M

Price

CTKB$5.43

CYRX$17.35

P/E Ratio

CTKBN/A

CYRXN/A

P/S Ratio

CTKB3.39x

CYRX4.69x

EV/Sales

CTKB3.08x

CYRX4.25x

EV/EBITDA

CTKB1,027.69x

CYRX1,004.45x

P/B Ratio

CTKB2.37x

CYRX1.80x

P/FCF Ratio

CTKBN/A

CYRXN/A

EV/FCF

CTKB-52.35x

CYRX-37.15x

PEG Ratio

CTKBN/A

CYRXN/A

Forward P/E (NTM)

CTKBN/A

CYRXN/A

Forward P/S (NTM)

CTKB3.18x

CYRX4.18x

Revenue (TTM)

CTKB$207M

CYRX$186M

Revenue Growth (YoY)

CTKB5.4%

CYRX-8.0%

Forward Rev Growth

CTKB6.1%

CYRX8.9%

Gross Margin (TTM)

CTKB53.2%

CYRX47.1%

Operating Margin (TTM)

CTKB0.0%

CYRX0.0%

EBITDA Margin (TTM)

CTKB-17.9%

CYRX-7.4%

Net Margin (TTM)

CTKB-39.0%

CYRX-24.3%

FCF Margin (TTM)

CTKB-5.9%

CYRX-11.4%

Net Income (TTM)

CTKB$-81M

CYRX$-45M

FCF (TTM)

CTKB$-12M

CYRX$-21M

EPS (TTM)

CTKB-$0.62

CYRX-$0.90

ROE (TTM)

CTKB-2353.0%

CYRX-747.0%

ROA (TTM)

CTKB-1740.0%

CYRX-489.0%

ROIC (TTM)

CTKB-2293.0%

CYRX-543.0%

Cash

CTKB$74M

CYRX$269M

Debt

CTKB$10M

CYRX$188M

Net Cash/Debt

CTKB$64M

CYRX$81M

Current Ratio (TTM)

CTKB4.48x

CYRX2.08x

Quick Ratio (TTM)

CTKB3.77x

CYRX1.96x

Debt/Equity (TTM)

CTKB0.03x

CYRX0.38x

Debt/Assets (TTM)

CTKB0.0%

CYRX0.0%

Interest Coverage (TTM)

CTKBN/A

CYRXN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

CYRX0.00x

Beta

CTKB1.15

CYRX1.88

52W Performance

CTKB39.2%

CYRX72.5%

YTD Performance

CTKB10.4%

CYRX81.5%

% from 52W High

CTKB-12.6%

CYRX-5.5%

% from 52W Low

CTKB64.0%

CYRX128.0%

Asset Turnover (TTM)

CTKB0.45x

CYRX0.24x

FCF Yield (TTM)

CTKB-1.7%

CYRX-2.4%

Earnings Yield (TTM)

CTKB-11.5%

CYRX-5.2%

Dividend Yield (TTM)

CTKBN/A

CYRXN/A

Rule of 40

CTKB-0.4

CYRX-19.5

EV/GP/RG

CTKB0.61

CYRX0.63

Ticker research

View CTKB research View CYRX research

Metric	CTKB Cytek Biosciences Inc	CYRX Cryoport Inc
Market & Valuation
Market Cap	$701M	$874M
Enterprise Value	$637M	$793M
Price	$5.43	$17.35
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	4.69x
EV/Sales	3.08x	4.25x
EV/EBITDA	1,027.69x	1,004.45x
P/B Ratio	2.37x	1.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-37.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	4.18x
Revenue & Growth
Revenue (TTM)	$207M	$186M
Revenue Growth (YoY)	5.4%	-8.0%
Forward Rev Growth	6.1%	8.9%
Profitability
Gross Margin (TTM)	53.2%	47.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-7.4%
Net Margin (TTM)	-39.0%	-24.3%
FCF Margin (TTM)	-5.9%	-11.4%
Net Income (TTM)	$-81M	$-45M
FCF (TTM)	$-12M	$-21M
EPS (TTM)	-$0.62	-$0.90
ROE (TTM)	-2353.0%	-747.0%
ROA (TTM)	-1740.0%	-489.0%
ROIC (TTM)	-2293.0%	-543.0%
Financial Health
Cash	$74M	$269M
Debt	$10M	$188M
Net Cash/Debt	$64M	$81M
Current Ratio (TTM)	4.48x	2.08x
Quick Ratio (TTM)	3.77x	1.96x
Debt/Equity (TTM)	0.03x	0.38x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	1.88
52W Performance	39.2%	72.5%
YTD Performance	10.4%	81.5%
% from 52W High	-12.6%	-5.5%
% from 52W Low	64.0%	128.0%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.24x
FCF Yield (TTM)	-1.7%	-2.4%
Earnings Yield (TTM)	-11.5%	-5.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-19.5
EV/GP/RG	0.61	0.63
Ticker research	View CTKB research	View CYRX research

Valuation

P/S Ratio

CTKB

3.39x

CYRX

4.69x

EV/FCF

CTKB

-52.35x

CYRX

-37.15x

Growth & revenue

Revenue Growth TTM

CTKB

5.4%

CYRX

-8.0%

Forward Revenue Growth

CYRX

8.9%

CTKB

6.1%

Profitability & performance

Gross Margin

CTKB

53.2%

CYRX

47.1%

ROE

CYRX

-747.0%

CTKB

-2353.0%

FCF Yield %

CTKB

-1.7%

CYRX

-2.4%

52-Week Performance

CYRX

72.5%

CTKB

39.2%

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

CYRX

Cryoport Inc

Market Cap

CTKB$701M

CYRX$874M

Enterprise Value

CTKB$637M

CYRX$793M

Price

CTKB$5.43

CYRX$17.35

P/E Ratio

CTKBN/A

CYRXN/A

P/S Ratio

CTKB3.39x

CYRX4.69x

EV/Sales

CTKB3.08x

CYRX4.25x

EV/EBITDA

CTKB1,027.69x

CYRX1,004.45x

P/B Ratio

CTKB2.37x

CYRX1.80x

P/FCF Ratio

CTKBN/A

CYRXN/A

EV/FCF

CTKB-52.35x

CYRX-37.15x

PEG Ratio

CTKBN/A

CYRXN/A

Forward P/E (NTM)

CTKBN/A

CYRXN/A

Forward P/S (NTM)

CTKB3.18x

CYRX4.18x

Revenue (TTM)

CTKB$207M

CYRX$186M

Revenue Growth (YoY)

CTKB5.4%

CYRX-8.0%

Forward Rev Growth

CTKB6.1%

CYRX8.9%

Gross Margin (TTM)

CTKB53.2%

CYRX47.1%

Operating Margin (TTM)

CTKB0.0%

CYRX0.0%

EBITDA Margin (TTM)

CTKB-17.9%

CYRX-7.4%

Net Margin (TTM)

CTKB-39.0%

CYRX-24.3%

FCF Margin (TTM)

CTKB-5.9%

CYRX-11.4%

Net Income (TTM)

CTKB$-81M

CYRX$-45M

FCF (TTM)

CTKB$-12M

CYRX$-21M

EPS (TTM)

CTKB-$0.62

CYRX-$0.90

ROE (TTM)

CTKB-2353.0%

CYRX-747.0%

ROA (TTM)

CTKB-1740.0%

CYRX-489.0%

ROIC (TTM)

CTKB-2293.0%

CYRX-543.0%

Cash

CTKB$74M

CYRX$269M

Debt

CTKB$10M

CYRX$188M

Net Cash/Debt

CTKB$64M

CYRX$81M

Current Ratio (TTM)

CTKB4.48x

CYRX2.08x

Quick Ratio (TTM)

CTKB3.77x

CYRX1.96x

Debt/Equity (TTM)

CTKB0.03x

CYRX0.38x

Debt/Assets (TTM)

CTKB0.0%

CYRX0.0%

Interest Coverage (TTM)

CTKBN/A

CYRXN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

CYRX0.00x

Beta

CTKB1.15

CYRX1.88

52W Performance

CTKB39.2%

CYRX72.5%

YTD Performance

CTKB10.4%

CYRX81.5%

% from 52W High

CTKB-12.6%

CYRX-5.5%

% from 52W Low

CTKB64.0%

CYRX128.0%

Asset Turnover (TTM)

CTKB0.45x

CYRX0.24x

FCF Yield (TTM)

CTKB-1.7%

CYRX-2.4%

Earnings Yield (TTM)

CTKB-11.5%

CYRX-5.2%

Dividend Yield (TTM)

CTKBN/A

CYRXN/A

Rule of 40

CTKB-0.4

CYRX-19.5

EV/GP/RG

CTKB0.61

CYRX0.63

Ticker research

View CTKB research View CYRX research

Metric	CTKB Cytek Biosciences Inc	CYRX Cryoport Inc
Market & Valuation
Market Cap	$701M	$874M
Enterprise Value	$637M	$793M
Price	$5.43	$17.35
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	4.69x
EV/Sales	3.08x	4.25x
EV/EBITDA	1,027.69x	1,004.45x
P/B Ratio	2.37x	1.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-37.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	4.18x
Revenue & Growth
Revenue (TTM)	$207M	$186M
Revenue Growth (YoY)	5.4%	-8.0%
Forward Rev Growth	6.1%	8.9%
Profitability
Gross Margin (TTM)	53.2%	47.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-7.4%
Net Margin (TTM)	-39.0%	-24.3%
FCF Margin (TTM)	-5.9%	-11.4%
Net Income (TTM)	$-81M	$-45M
FCF (TTM)	$-12M	$-21M
EPS (TTM)	-$0.62	-$0.90
ROE (TTM)	-2353.0%	-747.0%
ROA (TTM)	-1740.0%	-489.0%
ROIC (TTM)	-2293.0%	-543.0%
Financial Health
Cash	$74M	$269M
Debt	$10M	$188M
Net Cash/Debt	$64M	$81M
Current Ratio (TTM)	4.48x	2.08x
Quick Ratio (TTM)	3.77x	1.96x
Debt/Equity (TTM)	0.03x	0.38x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	1.88
52W Performance	39.2%	72.5%
YTD Performance	10.4%	81.5%
% from 52W High	-12.6%	-5.5%
% from 52W Low	64.0%	128.0%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.24x
FCF Yield (TTM)	-1.7%	-2.4%
Earnings Yield (TTM)	-11.5%	-5.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-19.5
EV/GP/RG	0.61	0.63
Ticker research	View CTKB research	View CYRX research